F. André

The Role of Next‐Generation Sequencing in Enabling Personalized Oncology Therapy

Lackner, F. André, Caitlyn Cummings, 2016, Clinical and translational science.

Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors

S. Lancel, B. Quesnel, F. André, 2016, Oncotarget.

GILZ overexpression attenuates endoplasmic reticulum stress-mediated cell death via the activation of mitochondrial oxidative phosphorylation.

B. Quesnel, F. André, T. Idziorek, 2016, Biochemical and biophysical research communications.

Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

D. Gautheret, Ismael Padioleau, P. Cournède, 2022, medRxiv.

Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM database

B. Dréno, N. Basset-Seguin, M. Beylot-Barry, 2021, ESMO open.

Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor

G. Garçon, S. Rocchi, M. Malet‐Martino, 2013, Oncotarget.

Metabolic rewiring in cancer cells overexpressing the glucocorticoid-induced leucine zipper protein (GILZ): Activation of mitochondrial oxidative phosphorylation and sensitization to oxidative cell death induced by mitochondrial targeted drugs.

B. Quesnel, M. Malet‐Martino, F. André, 2017, The international journal of biochemistry & cell biology.

[The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy].

F. André, A. Scherpereel, L. Mortier, 2019, Medecine sciences : M/S.